tiprankstipranks
Lee's Pharmaceutical Holdings Limited (HK:0950)
:0950
Hong Kong Market
0950
Lee's Pharmaceutical Holdings Limited
RESEARCH TOOLSreports
Want to see HK:0950 full AI Analyst Report?

Lee's Pharmaceutical Holdings Limited (0950) Ratios

0 Followers

Lee's Pharmaceutical Holdings Limited Ratios

HK:0950's free cash flow for Q4 2025 was HK$0.50. For the 2025 fiscal year, HK:0950's free cash flow was decreased by HK$ and operating cash flow was HK
gt;-0.01. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.03 1.03 1.02 1.01 1.00
Quick Ratio
 0.71 0.71 0.64 0.55 0.62
Cash Ratio
 0.31 0.31 0.28 0.26 0.29
Solvency Ratio
 0.18 0.16 0.23 0.18 0.22
Operating Cash Flow Ratio
 0.24 0.29 0.31 0.17 0.44
Short-Term Operating Cash Flow Coverage
 1.24 1.49 1.61 0.90 3.70
Net Current Asset Value
HK$ -394.34MHK$ -394.34MHK$ -284.38MHK$ -273.44MHK$ -287.87M
Leverage Ratios
Debt-to-Assets Ratio
 0.09 0.09 0.09 0.07 0.06
Debt-to-Equity Ratio
 0.15 0.15 0.14 0.10 0.08
Debt-to-Capital Ratio
 0.13 0.13 0.12 0.09 0.08
Long-Term Debt-to-Capital Ratio
 0.04 0.04 0.04 0.03 0.04
Financial Leverage Ratio
 1.69 1.69 1.58 1.42 1.45
Debt Service Coverage Ratio
 1.03 0.83 1.41 1.36 2.46
Interest Coverage Ratio
 6.67 5.48 8.19 3.66 10.08
Debt to Market Cap
 0.45 0.34 0.26 0.22 0.16
Interest Debt Per Share
 0.55 0.55 0.41 0.37 0.29
Net Debt to EBITDA
 -0.14 -0.18 0.04 0.17 -0.11
Profitability Margins
Gross Profit Margin
51.52%50.81%53.81%52.35%62.50%
EBIT Margin
5.39%4.28%8.00%4.14%6.21%
EBITDA Margin
15.31%15.12%18.63%18.33%18.58%
Operating Profit Margin
4.85%4.28%8.08%4.14%6.21%
Pretax Profit Margin
5.06%5.08%7.01%2.92%5.50%
Net Profit Margin
5.94%6.40%6.65%1.59%4.16%
Continuous Operations Profit Margin
3.18%3.52%4.90%1.89%3.72%
Net Income Per EBT
117.35%126.14%94.89%54.24%75.57%
EBT Per EBIT
104.19%118.55%86.72%70.68%88.64%
Return on Assets (ROA)
3.10%2.65%3.56%0.58%1.84%
Return on Equity (ROE)
5.66%4.49%5.64%0.82%2.67%
Return on Capital Employed (ROCE)
3.76%2.63%6.13%1.94%3.59%
Return on Invested Capital (ROIC)
2.16%1.67%3.95%1.19%2.33%
Return on Tangible Assets
5.07%4.35%6.30%0.92%2.92%
Earnings Yield
15.82%10.27%11.13%1.92%5.34%
Efficiency Ratios
Receivables Turnover
 9.46 7.52 6.78 8.14 8.28
Payables Turnover
 5.02 4.05 4.55 6.77 4.56
Inventory Turnover
 2.40 1.94 2.25 1.68 1.86
Fixed Asset Turnover
 4.70 3.73 3.49 2.38 2.28
Asset Turnover
 0.52 0.41 0.53 0.36 0.44
Working Capital Turnover Ratio
 41.59 54.79 132.45 225.51 58.35
Cash Conversion Cycle
 117.69 146.63 136.01 207.79 160.85
Days of Sales Outstanding
 38.60 48.57 53.85 44.86 44.08
Days of Inventory Outstanding
 151.87 188.30 162.30 216.87 196.73
Days of Payables Outstanding
 72.78 90.23 80.14 53.94 79.96
Operating Cycle
 190.47 236.86 216.15 261.73 240.81
Cash Flow Ratios
Operating Cash Flow Per Share
 0.47 0.57 0.41 0.19 0.48
Free Cash Flow Per Share
 0.42 0.17 0.06 -0.08 0.12
CapEx Per Share
 0.04 0.39 0.35 0.27 0.36
Free Cash Flow to Operating Cash Flow
 0.91 0.30 0.14 -0.45 0.25
Dividend Paid and CapEx Coverage Ratio
 5.90 1.28 1.07 0.65 1.19
Capital Expenditure Coverage Ratio
 10.54 1.44 1.17 0.69 1.33
Operating Cash Flow Coverage Ratio
 0.89 1.07 1.06 0.54 1.73
Operating Cash Flow to Sales Ratio
 0.15 0.23 0.17 0.10 0.23
Free Cash Flow Yield
50.84%11.32%4.12%-5.69%7.27%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 6.32 9.74 8.98 52.19 18.72
Price-to-Sales (P/S) Ratio
 0.37 0.62 0.60 0.83 0.78
Price-to-Book (P/B) Ratio
 0.33 0.44 0.51 0.43 0.50
Price-to-Free Cash Flow (P/FCF) Ratio
 2.71 8.83 24.27 -17.56 13.75
Price-to-Operating Cash Flow Ratio
 2.46 2.69 3.46 7.92 3.38
Price-to-Earnings Growth (PEG) Ratio
 0.21 0.00 0.02 -0.77 -0.19
Price-to-Fair Value
 0.33 0.44 0.51 0.43 0.50
Enterprise Value Multiple
 2.30 3.94 3.25 4.69 4.08
Enterprise Value
 637.53M 855.40M 846.64M 904.62M 933.99M
EV to EBITDA
 2.30 3.94 3.25 4.69 4.08
EV to Sales
 0.35 0.60 0.60 0.86 0.76
EV to Free Cash Flow
 1.85 8.44 24.57 -18.23 13.38
EV to Operating Cash Flow
 1.49 2.57 3.50 8.22 3.29
Tangible Book Value Per Share
 0.93 0.94 0.70 1.49 1.38
Shareholders’ Equity Per Share
 3.47 3.47 2.81 3.46 3.27
Tax and Other Ratios
Effective Tax Rate
 0.37 0.31 0.30 0.35 0.32
Revenue Per Share
 3.07 2.44 2.38 1.79 2.09
Net Income Per Share
 0.18 0.16 0.16 0.03 0.09
Tax Burden
 1.17 1.26 0.95 0.54 0.76
Interest Burden
 0.94 1.19 0.88 0.71 0.89
Research & Development to Revenue
 0.08 0.08 0.06 0.09 0.14
SG&A to Revenue
 0.40 0.39 0.43 0.18 0.16
Stock-Based Compensation to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
 3.98 4.57 2.47 6.59 4.18
Currency in HKD